Agilent Technologies said on Tuesday it would acquire pathology software maker Proscia for $240 million in cash, plus up to $30 million tied to future performance targets, as the laboratory equipment maker expands its push into AI-enabled diagnostics.
Privately held Proscia develops software that converts pathology slides into digital images that can be stored, reviewed and analyzed using artificial intelligence tools
Agilent said the acquisition would strengthen its pathology business and expand its presence in digital and AI-enabled diagnostics
The deal would provide Agilent access to a high-growth software business that generated more than $18 million in revenue over the past 12 months
The companies have worked together since 2022, when they entered a multi-year distribution agreement to offer a digital pathology system combining Agilent’s pathology products with Proscia’s software
The deal is expected to close early in Agilent’s fiscal 2027.
- Published On Oct 14, 2026 at 07:38 AM IST
Join the community of 2M+ industry professionals.
Subscribe to Newsletter to get latest insights & analysis in your inbox.
All about ETHealthworld industry right on your smartphone!
- Download the ETHealthworld App and get the Realtime updates and Save your favourite articles.
